The deep discount and severe dilution signal distress; expect further downside pressure as shares are absorbed. Monitor any subsequent use-of-proceeds updates or signs of operational progress, but near-term outlook remains negative.
Price Chart
Executive Summary
Regencell Bioscience is raising ~$20M in a registered direct offering of 985,222 shares at $20.30 each, a 27% discount to the prior close of $27.79. The pre-revenue, going-concern company will use net proceeds (~$18.4M) for working capital, but existing shareholders face massive dilution of $20.26 per share for new investors.
Key Facts
- 985,222 shares offered at $20.30/share, 27% below last closing price of $27.79
- Gross proceeds ~$20M; net proceeds ~$18.4M after fees and expenses
- As-adjusted net tangible book value per share rises from $0.0025 to $0.0396
- New investors experience immediate dilution of $20.26 per share
- Company has no revenue, $30.5M accumulated deficit, and a going-concern opinion
- Proceeds allocated to working capital and general corporate purposes
Financial Impact
Approximately $20M gross raised; dilution of $20.26 per share to new investors
Risk Factors
- Further stock price decline due to overhang from discounted offering
- Going-concern risk remains despite cash infusion
- Limited operating history and no approved products
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001213900-26-059114 |
| Document: ea029127201ex-fee.htm | 0001213900-26-059114 |
| Document: 0001213900-26-059114-index-headers.html | 0001213900-26-059114 |
| Document: 0001213900-26-059114-index.html | 0001213900-26-059114 |
| Document: 0001213900-26-059114.txt | 0001213900-26-059114 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 18d ago | 20-F | $7.63 $7.35 | ▲ +3.67% | ▲ +4.27% | $6.67 (+12.58%) |
May 22, 2026 22w ago | 6-K | $25.80 $24.31 | ▲ +5.78% | ▲ +6.36% | $6.67 (+74.15%) |
May 19, 2026 22w ago | 424B5 | $27.39 $27.00 | ▲ +1.42% | ▲ +1.62% | $6.67 (+75.65%) |
May 19, 2026 22w ago | 6-K | $27.00 $27.39 | ▲ +1.44% | ▲ +0.40% | $6.67 (−75.30%) |
May 8, 2026 24w ago | 6-K | $27.33 $26.35 | ▲ +3.59% | ▲ +3.45% | $6.67 (+75.59%) |
Apr 17, 2026 27w ago | 6-K | $28.10 $28.40 | ▼ −1.07% | ▼ −1.72% | $6.67 (+76.26%) |
Mar 30, 2026 30w ago | 6-K | $23.33 $25.43 | ▲ +9.00% | ▲ +6.11% | $6.67 (−71.41%) |
Mar 30, 2026 30w ago | 6-K | $23.33 $25.43 | ▲ +9.00% | ▲ +6.11% | $6.67 (−71.41%) |
Mar 30, 2026 30w ago | 424B5 | $23.33 $25.43 | ▲ +9.00% | ▲ +6.11% | $6.67 (−71.41%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers